MLTX
Price
$44.21
Change
+$0.19 (+0.43%)
Updated
Jun 13 closing price
Capitalization
2.81B
52 days until earnings call
NTRB
Price
$7.15
Change
-$0.45 (-5.92%)
Updated
Jun 13 closing price
Capitalization
79.58M
16 days until earnings call
Interact to see
Advertisement

MLTX vs NTRB

Header iconMLTX vs NTRB Comparison
Open Charts MLTX vs NTRBBanner chart's image
MoonLake Immunotherapeutics
Price$44.21
Change+$0.19 (+0.43%)
Volume$316.29K
Capitalization2.81B
Nutriband
Price$7.15
Change-$0.45 (-5.92%)
Volume$32.13K
Capitalization79.58M
MLTX vs NTRB Comparison Chart
Loading...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MLTX vs. NTRB commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLTX is a Hold and NTRB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 16, 2025
Stock price -- (MLTX: $44.21 vs. NTRB: $7.15)
Brand notoriety: MLTX and NTRB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLTX: 59% vs. NTRB: 54%
Market capitalization -- MLTX: $2.81B vs. NTRB: $79.58M
MLTX [@Biotechnology] is valued at $2.81B. NTRB’s [@Biotechnology] market capitalization is $79.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLTX’s FA Score shows that 0 FA rating(s) are green whileNTRB’s FA Score has 0 green FA rating(s).

  • MLTX’s FA Score: 0 green, 5 red.
  • NTRB’s FA Score: 0 green, 5 red.
According to our system of comparison, MLTX is a better buy in the long-term than NTRB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLTX’s TA Score shows that 6 TA indicator(s) are bullish while NTRB’s TA Score has 6 bullish TA indicator(s).

  • MLTX’s TA Score: 6 bullish, 4 bearish.
  • NTRB’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both MLTX and NTRB are a good buy in the short-term.

Price Growth

MLTX (@Biotechnology) experienced а -5.70% price change this week, while NTRB (@Biotechnology) price change was -7.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.63%. For the same industry, the average monthly price growth was +13.05%, and the average quarterly price growth was +4.06%.

Reported Earning Dates

MLTX is expected to report earnings on Aug 07, 2025.

NTRB is expected to report earnings on Jul 02, 2025.

Industries' Descriptions

@Biotechnology (-0.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($2.81B) has a higher market cap than NTRB($79.6M). NTRB YTD gains are higher at: 51.805 vs. MLTX (-18.356). NTRB has higher annual earnings (EBITDA): -9.68M vs. MLTX (-168.14M). MLTX has more cash in the bank: 480M vs. NTRB (2.96M). NTRB has less debt than MLTX: NTRB (282K) vs MLTX (75.6M). NTRB has higher revenues than MLTX: NTRB (2.4M) vs MLTX (0).
MLTXNTRBMLTX / NTRB
Capitalization2.81B79.6M3,525%
EBITDA-168.14M-9.68M1,737%
Gain YTD-18.35651.805-35%
P/E RatioN/AN/A-
Revenue02.4M-
Total Cash480M2.96M16,194%
Total Debt75.6M282K26,809%
FUNDAMENTALS RATINGS
NTRB: Fundamental Ratings
NTRB
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MLTXNTRB
RSI
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
67%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
64%
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
64%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
59%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 27 days ago
81%
Bullish Trend 19 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
74%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
64%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 5 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DIPS8.530.14
+1.67%
YieldMax Short NVDA Option Inc Strgy ETF
XAR197.83-0.61
-0.31%
SPDR® S&P Aerospace & Defense ETF
PFFR17.86-0.12
-0.69%
InfraCap REIT Preferred ETF
EWX60.99-1.14
-1.83%
SPDR® S&P Emerging Markets Small Cap ETF
AEF5.68-0.11
-1.90%
abrdn Emerging Markets ex-China Fund Inc.

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with DNLI. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+0.43%
DNLI - MLTX
46%
Loosely correlated
-2.51%
XENE - MLTX
45%
Loosely correlated
-0.12%
XNCR - MLTX
45%
Loosely correlated
-2.55%
KYMR - MLTX
44%
Loosely correlated
-0.70%
IDYA - MLTX
43%
Loosely correlated
-0.45%
More

NTRB and

Correlation & Price change

A.I.dvisor tells us that NTRB and REPL have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NTRB and REPL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTRB
1D Price
Change %
NTRB100%
-5.92%
REPL - NTRB
27%
Poorly correlated
-1.06%
STOK - NTRB
27%
Poorly correlated
-2.45%
RARE - NTRB
25%
Poorly correlated
-4.58%
GLMD - NTRB
24%
Poorly correlated
-0.62%
MLTX - NTRB
24%
Poorly correlated
+0.43%
More